# The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

> **Open Intelligence Dossier** · First detected: 2026-08-06 16:07 UTC · Category: Business

## Executive Summary
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings" is generating significant coverage in the Business category, with 3 articles from 3 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Fierce Pharma, BioSpace and CNBC. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| CNBC | The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings | [Source Link](https://news.google.com/rss/articles/CBMihwFBVV95cUxOb2dUNGllTE5tVDhEbmFKRmdLbzBkOEVhZGczREdGVjVGRnhVRUVKZVV6aENnZ3F6ZEhaSG45YU1LRXhYMkdJeEpXZWN1TGx3VEhRWHJURUlPUmJ5R3JkN1l1TlhUVnNfRWtkWE9pZUxiR1RCTFY4ZlNtRDFUa285aDhkN21EUUnSAYwBQVVfeXFMT3dIY2swa1BIbmc3Qkk5UjFQU19OdGh4MDVkNndVU0JKRDFpd3ZxMWxLQWhCTDRTekhXdnd1RTdYcEZQRGpUNlhUM1M5SGJPLVpKNTBZTUxYYmpkVGluUHVWUG5xQlFqUkFydG9JY3p4VUtiZWlzd0MzY0VBVDVtUkFJYnN3Y3lxT0poWkk?oc=5) |
| Fierce Pharma | Lilly’s obesity pill Foundayo ‘disappointed’ in Q2, as injectables continue to boom | [Source Link](https://news.google.com/rss/articles/CBMirgFBVV95cUxPQVV4RlFrUEswVTJLWVdkNVRNTXI0ajU3ZUppMFhnN0ktdkdwT2lndXNQUWNXUzNVYnJ1alFxRWIzYlJiQVYxU2VjdlBTR2JlWFVLZ05ZMjlUR0xpb2NnbDNsT2xIZ1hTX0xHSC0tLXI0RGh4UFl5SDI0UkZ4bWk1U01DYXhRSF9OT0dFWFY5WHVNdGxuT2d4dzkxdy02a0ZPUVZpWlB0cHpvRHVLYXc?oc=5) |
| BioSpace | Lilly confident in slow and steady Foundayo launch, as ex-US sales shine | [Source Link](https://news.google.com/rss/articles/CBMiqAFBVV95cUxNbkNuX0R4OE1LeE14aW9BMEsyUzc5cVJpbmRRVm5FYmh1U2t3dlFnSUxTU2tKakQ5Y3Rzc3lGTkE0UUNVbVQxcHJ0NkpmUWExMVlSc0dKT3haZmZsSVNFbjhCZWpNVUxLOC1UQlhyQkdocGFCd01qMTBYN3lVSFAwSDdtTjFEQThIREJJUGZFeU9iUDdVRHFZU29oM19yQmZpWmdtNW9vV2Y?oc=5) |
| CNBC | The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings | [Source Link](https://news.google.com/rss/articles/CBMihwFBVV95cUxOb2dUNGllTE5tVDhEbmFKRmdLbzBkOEVhZGczREdGVjVGRnhVRUVKZVV6aENnZ3F6ZEhaSG45YU1LRXhYMkdJeEpXZWN1TGx3VEhRWHJURUlPUmJ5R3JkN1l1TlhUVnNfRWtkWE9pZUxiR1RCTFY4ZlNtRDFUa285aDhkN21EUUk?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-08-06/the-divide-between-eli-lilly-and-novo-nordisk-is-widening-after-their-latest*